Interestingly, existing research on KLF12 has demonstrated its role in promoting the malignant progression of both pancreatic and ovarian cancers 57-60, yet a study by Celia S. L. and colleagues revealed that high expression of miR-141 in ovarian cancer inhibits KLF12 61, thus promoting peritoneal metastasis, indicating that the role of KLF12 requires further exploration. The gene discussed is KLF12; the disease is ovarian cancer.